182 related articles for article (PubMed ID: 35734823)
1. Clearance of atypical cutaneous manifestations of hyper-IgE syndrome with dupilumab.
Nihal A; Comstock JR; Holland KE; Singh AM; Seroogy CM; Arkin LM
Pediatr Dermatol; 2022 Nov; 39(6):940-942. PubMed ID: 35734823
[TBL] [Abstract][Full Text] [Related]
2. Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome.
Sogkas G; Hirsch S; Jablonka A; Witte T; Schmidt RE; Atschekzei F
Clin Immunol; 2020 Jun; 215():108452. PubMed ID: 32360519
[No Abstract] [Full Text] [Related]
3. The treatment efficacy of dupilumab in autosomal dominant hyper-immunoglobulin E syndrome with severe atopic dermatitis.
Li W; Qi Q; Wang W; Li D
Asia Pac Allergy; 2024 Mar; 14(1):39-41. PubMed ID: 38482457
[TBL] [Abstract][Full Text] [Related]
4. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
5. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
[TBL] [Abstract][Full Text] [Related]
6. Atopic dermatitis or hyper-IgE syndrome?
Ohameje NU; Loveless JW; Saini SS
Allergy Asthma Proc; 2006; 27(3):289-91. PubMed ID: 16913276
[TBL] [Abstract][Full Text] [Related]
7. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
[TBL] [Abstract][Full Text] [Related]
8. Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience.
Shamriz O; Rubin L; Simon AJ; Lev A; Barel O; Somech R; Korem M; Matza Porges S; Freund T; Hagin D; Garty BZ; Nahum A; Molho Pessach V; Tal Y
Front Immunol; 2022; 13():1044933. PubMed ID: 36605204
[TBL] [Abstract][Full Text] [Related]
9. Hyper IgE syndromes: clinical and molecular characteristics.
Al-Shaikhly T; Ochs HD
Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
[TBL] [Abstract][Full Text] [Related]
10. Cytokine imbalance in hyper-IgE syndrome: reduced expression of transforming growth factor beta and interferon gamma genes in circulating activated T cells.
Ohga S; Nomura A; Ihara K; Takahata Y; Suga N; Akeda H; Shibata R; Okamura J; Kinukawa N; Hara T
Br J Haematol; 2003 Apr; 121(2):324-31. PubMed ID: 12694256
[TBL] [Abstract][Full Text] [Related]
11. Clinical Profile of Hyper-IgE Syndrome in India.
Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
Front Immunol; 2021; 12():626593. PubMed ID: 33717144
[No Abstract] [Full Text] [Related]
12. Clinical Manifestation of Hyper IgE Syndrome Including Otitis Media.
Wu J; Hong L; Chen TX
Curr Allergy Asthma Rep; 2018 Aug; 18(10):51. PubMed ID: 30112673
[TBL] [Abstract][Full Text] [Related]
13. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
[TBL] [Abstract][Full Text] [Related]
14. Dupilumab for STAT3-Hyper-IgE Syndrome With Refractory Intestinal Complication.
Lu CW; Lee WI; Chung WH
Pediatrics; 2021 Sep; 148(3):. PubMed ID: 34417287
[TBL] [Abstract][Full Text] [Related]
15. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
[TBL] [Abstract][Full Text] [Related]
16. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
[TBL] [Abstract][Full Text] [Related]
17. Hyper-IgE and Carcinoma in CADINS Disease.
Pietzsch L; Körholz J; Boschann F; Sergon M; Dorjbal B; Yee D; Gilly V; Kämmerer E; Paul D; Kastl C; Laass MW; Berner R; Jacobsen EM; Roesler J; Aust D; Lee-Kirsch MA; Snow AL; Schuetz C
Front Immunol; 2022; 13():878989. PubMed ID: 35651609
[TBL] [Abstract][Full Text] [Related]
18. [Hyper IgE syndrome. Opportune diagnosis and management].
Orozco CV; Velásquez LH; Méndez NH; Augusto B; Salazar T
Rev Alerg Mex; 2008; 55(1):38-45. PubMed ID: 18697452
[TBL] [Abstract][Full Text] [Related]
19. Investigation of Skin Barrier Functions and Allergic Sensitization in Patients with Hyper-IgE Syndrome.
Mócsai G; Gáspár K; Dajnoki Z; Tóth B; Gyimesi E; Bíró T; Maródi L; Szegedi A
J Clin Immunol; 2015 Oct; 35(7):681-8. PubMed ID: 26453584
[TBL] [Abstract][Full Text] [Related]
20. Hyper IgE Syndromes.
Gracci S; Novelli T; D'Elios S; Bernardini R; Peroni D
Curr Pediatr Rev; 2024; 20(3):253-264. PubMed ID: 37702167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]